Abbott’s Dissolving Heart Stent Clears Arteries in Trial Abbott Laboratories (ABT)’ disappearing stent, inserted to prop open a clogged artery and absorbed by the body over time, performed about as well as the company’s market-leading Xience device in its first scientific trial. The study showed some early signals of unique benefits and risks from the device, known as Absorb, though patients getting either therapy fared about the same. The findings presented at a conference today in Washington should be reassuring for doctors and patients in Europe, where it has been on the market for the past three years, said investigator Patrick Serruys, head of interventional cardiology at Erasmus University Hospital in the Netherlands. “At the end of the day, we have shown that in this patient population and in this trial, Absorb is performing as well as Xience, and Xience was very good,” said John Capek, the Abbott Park, Illinois-based company’s executive vice president for medical devices. “Perhaps we are seeing what was reported to be some of the benefits of Absorb, even at one year — a more patient-friendly implant that has the opportunity to reduce angina.” Patients treated with Absorb reported less chest pain, a complication that can lead to repeat procedures to clear the arteries, [...] ilinnews/abbotts-dissolving-heart-stent-clears-arteries-in-trial/
Posted on: Sun, 14 Sep 2014 17:02:07 +0000
Trending Topics
Recently Viewed Topics
© 2015